Arthur M. Cohen & Associates’s enVVeno Medical NVNO Stock Holding History

Arthur M. Cohen & Associates’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-400	Closed	-$44.8K	–	143
2024 Q3	$44.8K	Hold	400	–	–	0.01%	140
2024 Q2	$73.5K	Buy	+400	New	+$69.8K	0.01%	139
2024 Q1	–	Sell	-400	Closed	-$72K	–	143
2023 Q4	$72K	Hold	400	–	–	0.02%	138
2023 Q3	$75.5K	Hold	400	–	–	0.02%	128
2023 Q2	$43.1K	Sell	400 -286	-42%	-$37.1K	0.01%	137
2023 Q1	$112K	Hold	686	–	–	0.03%	128
2022 Q4	$122K	Hold	686	–	–	0.03%	124
2022 Q3	$151K	Hold	686	–	–	0.04%	122
2022 Q2	$91K	Buy	686 +257	+60%	+$39.9K	0.02%	129
2022 Q1	$96K	Buy	429 +29	+7%	+$5.63K	0.02%	138
2021 Q4	$92K	Buy	+400	New	+$113K	0.02%	144

Other funds holding NVNO

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arthur M. Cohen & Associates's NVNO Position: Q4 2024 in Review

Arthur M. Cohen & Associates sold out of enVVeno Medical (NVNO) in Q4 2024, closing a stake of 400 shares — an estimated $44.8K sold.

Arthur M. Cohen & Associates first reported a position in NVNO in Q4 2021 and held it in 11 quarters. The position peaked at $151K in Q3 2022. 34 funds tracked by Wall St. Rank hold NVNO as of Q4 2024.

Arthur M. Cohen & Associates reported no remaining enVVeno Medical position as of Q4 2024 after selling out during the quarter.
Arthur M. Cohen & Associates sold 400 enVVeno Medical shares in Q4 2024, an estimated $44.8K.
Arthur M. Cohen & Associates first reported a position in enVVeno Medical in Q4 2021 and held it in 11 quarters.
Arthur M. Cohen & Associates's enVVeno Medical position peaked at $151K in Q3 2022.
34 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2024.

Based on Arthur M. Cohen & Associates's 13F filing for Q4 2024, filed 15 Jan 2025.